Novartis AG Other Expense By Function
Novartis AG (NVSEF) reported Other Expense By Function of $2.34 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:OtherExpenseByFunction · last filed 2026-02-04
- Novartis AG other expense by function for the quarter ending 2025-06-30 was $1.03B, a 105.80% increase year-over-year.
- Novartis AG other expense by function for the quarter ending 2024-06-30 was $500.00M, a 48.81% increase year-over-year.
- Novartis AG other expense by function for the quarter ending 2023-06-30 was $336.00M, a 74.74% decline year-over-year.
- Novartis AG other expense by function for the quarter ending 2022-06-30 was $1.33B, a 157.75% increase year-over-year.
| Period end | Other Expense By Function 3 month | Other Expense By Function 3 month as first filed | Other Expense By Function 6 month | Other Expense By Function 6 month as first filed | Other Expense By Function 12 month | Other Expense By Function 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $2.34B 20-F · filed 2026-02-04 | |||||
| 2025-06-30 | $1.03B 6-K · filed 2025-07-17 | $1.56B 6-K · filed 2025-07-17 | ||||
| 2024-12-31 | $2.94B 20-F · filed 2026-02-04 | |||||
| 2024-06-30 | $500.00M 6-K · filed 2025-07-17 | $1.14B 6-K · filed 2025-07-17 | ||||
| 2023-12-31 | $2.30B 20-F · filed 2026-02-04 | |||||
| 2023-06-30 | $336.00M 6-K · filed 2024-07-18 | $610.00M 6-K · filed 2023-07-18 | $1.27B 6-K · filed 2024-07-18 | $1.76B 6-K · filed 2023-07-18 | ||
| 2022-12-31 | $3.26B 20-F · filed 2025-01-31 | $3.70B 20-F · filed 2023-02-01 | ||||
| 2022-06-30 | $1.33B 6-K · filed 2023-07-18 | $1.83B 6-K · filed 2023-07-18 | ||||
| 2021-12-31 | $2.33B 20-F · filed 2024-01-31 | $2.75B 20-F · filed 2022-02-02 | ||||
| 2021-06-30 | $516.00M 6-K · filed 2022-07-19 | $1.22B 6-K · filed 2022-07-19 | ||||
| 2020-12-31 | $3.19B 20-F/A · filed 2023-05-15 | |||||
| 2020-06-30 | $464.00M 6-K · filed 2021-07-21 | $1.42B 6-K · filed 2021-07-21 | ||||
| 2019-12-31 | $3.43B 20-F · filed 2022-02-02 | |||||
| 2019-06-30 | $1.31B 6-K · filed 2020-07-21 | $1.84B 6-K · filed 2020-07-21 | ||||
| 2018-12-31 | $2.61B 20-F · filed 2021-01-26 | $2.73B 20-F · filed 2019-01-30 | ||||
| 2018-06-30 | $524.00M 6-K · filed 2019-07-18 | $565.00M 6-K · filed 2018-07-18 | $987.00M 6-K · filed 2019-07-18 | $1.06B 6-K · filed 2018-07-18 | ||
| 2017-12-31 | $2.14B 20-F · filed 2020-01-29 | $2.33B 6-K · filed 2018-01-24 | ||||
| 2017-06-30 | $568.00M 6-K · filed 2018-07-18 | $1.13B 6-K · filed 2018-07-18 | ||||
| 2016-12-31 | $2.34B 20-F · filed 2019-01-30 | |||||
| 2015-12-31 | $2.87B 6-K · filed 2018-01-24 |